|
Volumn 10, Issue 5, 2011, Pages 328-
|
Deal watch: HGS and FivePrime in FGF 'ligand trap' deal.
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
FIBROBLAST GROWTH FACTOR;
FIBROBLAST GROWTH FACTOR RECEPTOR 1;
FP 1039;
FP-1039;
IMMUNOGLOBULIN G;
LIGAND;
ONCOPROTEIN;
DRUG DESIGN;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
METABOLISM;
NEOPLASM;
NOTE;
ORGANIZATION AND MANAGEMENT;
PATHOLOGY;
PROTEIN BINDING;
DRUG DESIGN;
DRUG INDUSTRY;
FIBROBLAST GROWTH FACTORS;
HUMANS;
IMMUNOGLOBULIN G;
LIGANDS;
NEOPLASMS;
ONCOGENE PROTEINS, FUSION;
PROTEIN BINDING;
RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1;
|
EID: 79959780454
PISSN: None
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd3448 Document Type: Note |
Times cited : (21)
|
References (0)
|